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Abstract: Zinc oxide nanoparticles (ZnO-NPs) were synthesized via a solvothermal method 
in triethanolamine (TEA) media. TEA was utilized as a polymer agent to terminate the growth 
of ZnO-NPs. The ZnO-NPs were characterized by a number of techniques, including X-ray 
diffraction analysis, transition electron microscopy, and field emission electron microscopy. The 
ZnO-NPs prepared by the solvothermal process at 150°C for 18 hours exhibited a hexagonal 
(wurtzite) structure, with a crystalline size of 33 ± 2 nm, and particle size of 48 ± 7 nm. The 
results confirm that TEA is a suitable polymer agent to prepare homogenous ZnO-NPs.
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Introduction
Understanding the mechanisms of the human body at the molecular and nanometer 
scale has improved tremendously, but developments in therapeutic options for   treating 
severe and debilitating diseases such as cancer and autoimmunity have lagged by 
comparison.1 In this regard, nanomedicine, which is the application of nanotechnol-
ogy to medical problems, can offer new approaches in therapy. The application of 
  nanotechnology in biology requires further studies for the development of new materials 
in the nanosize range. These materials have many potential applications in biological 
science and clinical medicine.2,3
One of the better-known materials that have been widely used for medical applications 
is zinc oxide nanoparticles (ZnO-NPs). It is not too far from the truth to say that the ZnO 
is a magic material because of its wide area of applications and flexibility of preparation 
in different morphologies with different properties. Reflecting the basic properties of ZnO, 
fine particles of the oxide have deodorizing and antibacterial action, and for that reason 
are added into various materials including cotton fabric, rubber, and food packaging.4,5 
ZnO is widely used to treat a variety of other skin conditions, in products such as baby 
powder and barrier creams to treat diaper rashes, and in calamine cream, antidandruff 
shampoos, and antiseptic ointments.6,7 It is also a component in tape (called “zinc oxide 
tape”) used by athletes as a bandage to prevent soft tissue damage during workouts.8 
Therefore, several new routes have been developed to synthesize ZnO-NPs, such as a 
wet polymerization method, sol-gel, sol-gel combustion, precipitation, hydrothermal, 
solvothermal, chemical vapor deposition (CVD), microwave assisted, a sonochemical 
method, and thermal oxidation.9–18 Some of these methods have   limitations. For example, 
it is not easy to control the growth of the ZnO nanostructures in the microwave, sol-gel, 
and sol-gel combustion methods because of the speed of the reactions. We have tried International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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to develop a better controlled method that is reliable, safe, 
and cheap.
In this work, a simple solvothermal method was used 
to prepare the ZnO-NPs. The aim of this research is the 
  preparation of ZnO-NPs with a narrow size   distribution 
that are suitable for medical applications such as in 
  sunscreen   protection. Triethanolamine (TEA) was used as a 
  polymerization agent in order to control the morphology of 
the ZnO-NPs because of its special structure. The reaction 
mechanism and effect of TEA were investigated.
Experimental
Zinc acetate (Zn(CH3COO)2.2H2O), ethanol, and TEA were 
used as starting materials. 0.5 M zinc acetate solution was 
prepared by dissolving 7.68 g of zinc acetate in 35 mL of 
ethanol. The solution was stirred at 60°C, and then the TEA 
was added to the solution, all at one time. The molar ratio of 
TEA/Zn2+ was fixed at 1:1. The solution was stirred at 60°C 
for 1 hour. After the stirring period, a clear and   homogenous 
solution was obtained. The Zn2+ solution was then aged at 
room temperature for another hour. The solutions were 
poured in a stainless steel autoclave in a 50 mL Teflon 
  vessel, and placed in the furnace for 18 hours at 150°C. 
The sample was then cooled down to room temperature. The 
formed white precipitates were dispersed in ethanol solution 
(30% in deionized water). The precipitates were separated 
by   centrifugation of the mixture (4000 rpm for 4 minutes) 
at room temperature. These washing steps were repeated 
3 times to remove the TEA polymers. Subsequently, the white 
precipitates were dried in an oven at 60°C overnight.
The structure of the prepared ZnO-NPs was characterized 
by powder X-ray diffraction (XRD, Philips, X’pert, Cu Kα). 
Field emission scanning electron microscopy (FESEM) and 
transmission electron microscopy (TEM, Hitachi H-7100 
electron microscope) were used to study the morphology 
of the ZnO-NPs. The UV-vis spectra were recorded over 
the range of 200–1000 nm by a UV-vis Evolution 300 PC 
(Thermo Scientific, Japan).
Results and discussion
The mechanism of ZnO-NPs formation
In the solvothermal process, alcohol plays a very important 
role in contributing the unoccupied oxygen to Zn2+ in order 
to form ZnO.19 The formed ZnO seeds are attracted to some 
of the TEA chains because of the ionic–dipolar interaction 
between the hydrogen atoms in the polymer and oxygen in 
the ZnO. The ZnO-NPs will grow with the association of 
the ZnO seeds. On the other hand, some of the TEA chains 
are attracted to each other by hydrogen-bonding forces. So, 
the growth of the particles will be eliminated, because the 
polymer chains do not permit the ZnO seeds to reach each 
other easily. The complete process is shown in Figure 1.
Fourier transform infrared spectroscopy 
(FTIR) analysis
Figure 2 shows the FTIR of the ZnO-NPs prepared by the 
solvothermal method, in the range of 4000–280 cm−1. A broad 
absorption band was observed at around 375 cm−1. The band 
at 375 cm−1 corresponds to the E2 mode of hexagonal ZnO 
(Raman active).11 There were several small absorption bands 
at 930, 1050, and 3400 cm−1. These absorption bands were 
likely related to CO2 (C-O) and H2O (O-H) absorbed from the 
atmosphere (air), and can therefore be neglected. The FTIR 
results show the high purity of the obtained ZnO-NPs.
XRD
The XRD pattern of the ZnO-NPs prepared by the solvothermal 
process at 150°C for 18 hours is shown in Figure 3. All detect-
able peaks can be indexed to ZnO wurtzite structure (PDF code 
no: 00-036-1451). The wurtzite lattice parameters, for example 
the values of d, the distances between adjacent crystal planes 
(hkl), were calculated from the Bragg equation, λ = 2d sinθ. 
The lattice constants a, b, and c; the inter-planar angles, the 
angle ϕ between the planes (h1k1l1) of spacing d1 and the plane 
(h2k2l2) of spacing d2; and V, the primary cell volumes, were 
calculated from the Lattice Geometry equation.20 The (100) and 
(002) planes were used to calculate the lattice parameters of the 
prepared ZnO-NPs, and the following values were obtained: 
d(100) = 0.2787 nm, d(002) = 0.2598 nm, a = b = 0.3218 nm, 
c = 0.5195 nm, ϕ = 90°, and V = 46.58 nm3.
The Scherrer equation, D = (kλ/βhklcosθ), was used to 
determine the crystalline sizes of the ZnO-NPs where D is the 
crystalline size in nanometers (nm), λ is the wavelength of 
the radiation (1.54056 Å for CuKα radiation), k is a constant 
equal to 0.94, βhkl is the peak width at half-maximum inten-
sity, and θ is the peak position. The (102) plane was chosen 
to calculate the crystalline size (either plane can be used for 
this purpose). The crystalline sizes of the ZnO-NPs prepared 
at 150°C for 18 hours were observed to be 33 ± 2 nm.
Optical properties
The room temperature UV-vis absorption spectra of   ZnO-NPs 
are shown in Figure 4. The ZnO-NPs were dispersed in 
ethanol with concentration of 0.1% wt and then the   solution 
was used to perform the UV-vis measurement. The spectrum 
reveals a characteristic absorption peak of ZnO at wavelength International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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of 370 nm which can be assigned to the intrinsic band-gap 
absorption of ZnO due to the electron transitions from the 
valence band to the conduction band (O2p → Zn3d).11 In addi-
tion, this sharp peak shows that the particles are in nanosize, 
and the particle size distribution is narrow. It is clearly shown 
that the maximum peak in the absorbance spectrum does 
not correspond to the true optical band gap of the ZnO-NPs. 
A common way to obtain the band gap from absorbance 
  spectra is to get the first derivative of the absorbance with 
respect to photon energy and find the maximum in the deriva-
tive spectrum at the lower energy sides.21 The derivative of the 
absorbance of the ZnO-NPs is shown in the inset of Figure 4, 
and it indicates a band gap of 3.3 eV for the ZnO-NPs. The 
good absorption of the ZnO-NPs in the UV region proves the 
applicability of this product in such medical application such 
as sunscreen protectors or as antiseptic ointments.7
TEA
ZnO seed
ZnO-NP Temperature
Zinc oxide seeds Zinc oxide nanoparticles
150°C
Figure 1 The schematic image of formation of the zinc oxide nanoparticles from the zinc oxide seed, and the role of triethanolamine as a polymerization agent.
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Figure 2 The Fourier transform infrared spectroscopy pattern of the zinc oxide 
nanoparticles prepared by the solvothermal method at 150°C.
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Figure 3 The X-ray diffraction pattern of the zinc oxide nanoparticles prepared by 
the solvothermal method at 150°C.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1402
Khorsand Zak et al
2.5
2
1.5
1
0.5
0
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
λ /nm
A
b
s
o
r
b
a
n
c
e
 
/
 
%
10
8
6
4
2
0
2.8 3 3.2 3.4 3.6 3.8
−2
−4
E (eV)
dA
dE
3.3 eV
Figure 4 The UV-vis absorbance spectrum of zinc oxide nanoparticles from 200 nm to 1000 nm. Inset shows the derivative of the absorbance spectrum.
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Figure 5 The transmission electron micrograph morphology image of zinc oxide nanoparticles (ZnO-NPs) (A), the scanning electron micrograph of the ZnO-NPs (B), and 
the particle size distribution of the ZnO-NPs (C).
Morphology
Figure 5 (A, B, and C) shows the TEM, SEM, and size distri-
bution of the ZnO-NPs prepared by the solvothermal method 
at 150°C for 18 hours. The TEM (Figure 5A) shows that the 
ZnO-NPs have grown in a near-hexagonal shape, which 
demonstrates the good quality of the ZnO-NPs. Figure 5B 
shows the SEM micrograph of the ZnO-NPs at 150,000X 
magnification. The SEM figure indicates a homogeneous 
shape and size for ZnO-NPs. Also, it shows the ZnO-NPs 
are well dispersed in the powder form. The size histograms 
of the ZnO-NPs are shown in Figure 5c. The histograms 
indicate that the main particle sizes of the ZnO-NPs made by 
the solvothermal method at temperature of 150°C for 6 hours 
is about 48 ± 7 nm.
The TEM, SEM, and size distribution results confirm 
that a narrow size distribution can be obtained for ZnO-NPs 
prepared by a solvothermal method using TEA as a polymer-
ization agent, compared to some of the other results.10–12International Journal of Nanomedicine
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Conclusion
The ZnO-NPs were made successfully by a solvothermal 
method at the low temperature of 150°C for 18 hours. TEA 
was used as a polymerization agent to control the growth 
of the ZnO-NPs because of its special structure that termi-
nates the growth of the ZnO-NPs. The XRD results show 
that the ZnO-NPs were formed in a hexagonal structure 
with crystalline size of 33 ± 2 nm. A sharp absorption peak 
(370 nm) was detected in the UV-vis region that corresponds 
to an optical band gap of the ZnO-NPs which was found 
to be 3.3 eV . TEM shows that the ZnO-NPs exhibit a near-
hexagonal shape according to their crystalline structure. The 
ZnO powder was very homogeneous, as shown by SEM. The 
average particle size of 48 ± 7 nm was obtained for ZnO-NPs 
from the particle size distribution graph. The results confirm 
the quality of the ZnO-NPs, which make them suitable for 
medical applications.
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